BR9708162A - Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal - Google Patents

Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal

Info

Publication number
BR9708162A
BR9708162A BR9708162A BR9708162A BR9708162A BR 9708162 A BR9708162 A BR 9708162A BR 9708162 A BR9708162 A BR 9708162A BR 9708162 A BR9708162 A BR 9708162A BR 9708162 A BR9708162 A BR 9708162A
Authority
BR
Brazil
Prior art keywords
replacement therapy
hormone replacement
progesterone antagonist
antagonist combination
sequential estrogen
Prior art date
Application number
BR9708162A
Other languages
English (en)
Inventor
Kristof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9708162A publication Critical patent/BR9708162A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
BR9708162A 1996-03-11 1997-03-11 Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal BR9708162A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (de) 1996-03-11 1996-03-11 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
PCT/DE1997/000580 WO1997033589A1 (de) 1996-03-11 1997-03-11 Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie

Publications (1)

Publication Number Publication Date
BR9708162A true BR9708162A (pt) 1999-07-27

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708162A BR9708162A (pt) 1996-03-11 1997-03-11 Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal

Country Status (16)

Country Link
EP (1) EP0889727B1 (pt)
JP (1) JP2000506175A (pt)
KR (1) KR19990087672A (pt)
AT (1) ATE319454T1 (pt)
AU (1) AU2691197A (pt)
BR (1) BR9708162A (pt)
CA (1) CA2248841C (pt)
DE (2) DE19610635A1 (pt)
DK (1) DK0889727T3 (pt)
ES (1) ES2260792T3 (pt)
HU (1) HUP9901474A3 (pt)
IL (1) IL126176A (pt)
NO (1) NO324613B1 (pt)
PL (1) PL328809A1 (pt)
PT (1) PT889727E (pt)
WO (1) WO1997033589A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
HUP0202460A3 (en) * 1999-08-31 2004-04-28 Schering Ag Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
EP1210951B1 (en) * 2000-11-30 2005-02-02 Pfizer Products Inc. Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
AU2691197A (en) 1997-10-01
ES2260792T3 (es) 2006-11-01
DE19610635A1 (de) 1997-09-18
CA2248841C (en) 2008-07-22
KR19990087672A (ko) 1999-12-27
DE59712593D1 (de) 2006-05-04
DK0889727T3 (da) 2006-07-03
IL126176A0 (en) 1999-05-09
NO984166D0 (no) 1998-09-10
PL328809A1 (en) 1999-02-15
HUP9901474A3 (en) 2000-02-28
CA2248841A1 (en) 1997-09-18
PT889727E (pt) 2006-07-31
EP0889727B1 (de) 2006-03-08
HUP9901474A2 (hu) 1999-09-28
WO1997033589A1 (de) 1997-09-18
NO324613B1 (no) 2007-11-26
IL126176A (en) 2004-12-15
NO984166L (no) 1998-09-10
JP2000506175A (ja) 2000-05-23
EP0889727A1 (de) 1999-01-13
ATE319454T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
NL300381I2 (nl) Estradiolvaleraat en dienogest
ATE286725T1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
BR9708162A (pt) Combinação de antagonista estrogênio/progesterona sequencial para a terapia de substituição hormonal
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
PL348202A1 (en) Pharmaceutically active composition and dispensing device
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
BR0213466A (pt) Uso de (11beta,17beta)-11-(1,3- benzodioxol-s-il)-17-hidróxi-17-(1-propinil) estra-4,9-dien-3-ona, preparação farmacêutica, e, método para o tratamento de um paciente sofrendo de distúrbio depressivo grave
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter
AR002283A1 (es) Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.
HUP9903097A2 (hu) Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
MX9707719A (es) Preparado en combinacion que contiene tramadol y un antagonista del canal de calcio.
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]